Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · IEX Real-Time Price · USD
5.09
+0.03 (0.59%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $417.95 million as of March 28, 2024. Its market cap has decreased by -41.14% in one year.
Market Cap
417.95M
Enterprise Value
274.19M
1-Year Change
-41.14%
Ranking
Category
Stock Price
$5.09
Market Cap Chart
Since January 25, 2007, Anavex Life Sciences's market cap has increased from $59.50M to $417.95M, an increase of 602.44%. That is a compound annual growth rate of 12.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 415.50M | 4.55% |
Mar 26, 2024 | 397.40M | 6.37% |
Mar 25, 2024 | 373.60M | -2.35% |
Mar 22, 2024 | 382.60M | -8.82% |
Mar 21, 2024 | 419.60M | -0.19% |
Mar 20, 2024 | 420.40M | 5.79% |
Mar 19, 2024 | 397.40M | 0.40% |
Mar 18, 2024 | 395.80M | -5.67% |
Mar 15, 2024 | 419.60M | -0.59% |
Mar 14, 2024 | 422.10M | -4.46% |
Mar 13, 2024 | 441.80M | 3.47% |
Mar 12, 2024 | 427.00M | 0.19% |
Mar 11, 2024 | 426.20M | -4.76% |
Mar 8, 2024 | 447.50M | 5.00% |
Mar 7, 2024 | 426.20M | 3.40% |
Mar 6, 2024 | 412.20M | 0.81% |
Mar 5, 2024 | 408.90M | -2.55% |
Mar 4, 2024 | 419.60M | -3.23% |
Mar 1, 2024 | 433.60M | 2.72% |
Feb 29, 2024 | 422.10M | -3.01% |
Feb 28, 2024 | 435.20M | -0.57% |
Feb 27, 2024 | 437.70M | 7.04% |
Feb 26, 2024 | 408.90M | 1.21% |
Feb 23, 2024 | 404.00M | -1.80% |
Feb 22, 2024 | 411.40M | -1.37% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lexeo Therapeutics | 410.34M |
Sonida Senior Living | 408.54M |
Neurogene | 406.51M |
Mesoblast | 398.82M |
Terns Pharmaceuticals | 398.25M |
Zynex | 397.30M |
Clover Health Investments | 391.78M |
ESSA Pharma | 391.51M |